{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:00:54Z","timestamp":1790359254292,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1038\/sj.bjc.6600595","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T10:59:50Z","timestamp":1034765990000},"page":"1013-1018","source":"Crossref","is-referenced-by-count":76,"title":["Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg\/Pro germline heterozygotes"],"prefix":"10.1038","volume":"87","author":[{"given":"E D","family":"Papadakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Soulitzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D A","family":"Spandidos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,10,21]]},"reference":[{"key":"BF6600595_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00008469-200004000-00007","volume":"9","author":"T Agorastos","year":"2000","unstructured":"Agorastos T, Lambropoulos AF, Constantinidis TC, Kotsis A, Bontis JN (2000) p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. Eur J Cancer Prev 9: 113\u2013118","journal-title":"Eur J Cancer Prev"},{"key":"BF6600595_CR2","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1054\/bjoc.2001.2085","volume":"85","author":"S Andersson","year":"2001","unstructured":"Andersson S, Rylander E, Strand A, Sallstrom J, Wilander E (2001) The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas. Br J Cancer 85: 1153\u20131156","journal-title":"Br J Cancer"},{"key":"BF6600595_CR3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1159\/000154228","volume":"44","author":"G Beckman","year":"1994","unstructured":"Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, Beckman L (1994) Is p53 polymorphism maintained by natural selection?. Hum Hered 44: 266\u2013270","journal-title":"Hum Hered"},{"key":"BF6600595_CR4","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1093\/carcin\/16.9.2233","volume":"16","author":"R Birgander","year":"1995","unstructured":"Birgander R, Sjalander A, Rannug A, Alexandrie AK, Sundberg MI, Seidegard J, Tornling G, Beckman G, Beckman L (1995) p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis 16: 2233\u20132236","journal-title":"Carcinogenesis"},{"key":"BF6600595_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1165\/ajrcmb.18.2.3033","volume":"18","author":"T Bohlmeyer","year":"1998","unstructured":"Bohlmeyer T, Le TN, Shroyer AL, Markham N, Shroyer KR (1998) Detection of human papillomavirus in squamous cell carcinomas of the lung by polymerase chain reaction. Am J Respir Cell Mol Biol 18: 265\u2013269","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF6600595_CR6","first-page":"6875","volume":"60","author":"LA Brooks","year":"2000","unstructured":"Brooks LA, Tidy JA, Gusterson B, Hiller L, O'Nions J, Gasco M, Marin MC, Farrell PJ, Kaelin Jr WG, Crook T (2000) Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus. Cancer Res 60: 6875\u20136877","journal-title":"Cancer Res"},{"key":"BF6600595_CR7","first-page":"2799","volume":"61","author":"YW Cheng","year":"2001","unstructured":"Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, Su JM, Lee H (2001) The association of human papillomavirus 16\/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 61: 2799\u20132803","journal-title":"Cancer Res"},{"key":"BF6600595_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1347::AID-CNCR10>3.0.CO;2-2","volume":"88","author":"CE Clavel","year":"2000","unstructured":"Clavel CE, Nawrocki B, Bosseaux B, Poitevin G, Putaud IC, Mangeonjean CC, Monteau M, Birembaut PL (2000) Detection of human papillomavirus DNA in bronchopulmonary carcinomas by hybrid capture II: a study of 185 tumors. Cancer 88: 1347\u20131352","journal-title":"Cancer"},{"key":"BF6600595_CR9","first-page":"405","volume":"5","author":"DN Dokianakis","year":"2000","unstructured":"Dokianakis DN, Koumantaki E, Billiri K, Spandidos DA (2000) p53 codon 72 polymorphism as a risk factor in the development of HPV-associated non-melanoma skin cancers in immunocompetent hosts. Int J Mol Med 5: 405\u2013409","journal-title":"Int J Mol Med"},{"key":"BF6600595_CR10","first-page":"1327","volume":"6","author":"DN Dokianakis","year":"1999","unstructured":"Dokianakis DN, Papaefthimiou M, Tsiveleka A, Spandidos DA (1999) High prevalence of HPV18 in correlation with ras gene mutations and clinicopathological parameters in cervical cancer studied from stained cytological smears. Oncol Rep 6: 1327\u20131331","journal-title":"Oncol Rep"},{"key":"BF6600595_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1006\/mcbr.2000.0196","volume":"3","author":"DN Dokianakis","year":"2000","unstructured":"Dokianakis DN, Spandidos DA (2000) p53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. Mol Cell Biol Res Commun 3: 111\u2013114","journal-title":"Mol Cell Biol Res Commun"},{"key":"BF6600595_CR12","first-page":"1037","volume":"9","author":"R Fan","year":"2000","unstructured":"Fan R, Wu MT, Miller D, Wain JC, Kelsey KT, Wiencke JK, Christiani DC (2000) The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 9: 1037\u20131042","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6600595_CR13","first-page":"1192","volume":"8","author":"M Furihata","year":"2002","unstructured":"Furihata M, Takeuchi T, Matsumoto M, Kurabayashi A, Ohtsuki Y, Terao N, Kuwahara M, Shuin T (2002) p53 mutation arising in Arg72 allele in the tumorigenesis and development of carcinoma of the urinary tract. Clin Cancer Res 8: 1192\u20131195","journal-title":"Clin Cancer Res"},{"key":"BF6600595_CR14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1054\/bjoc.1999.0993","volume":"82","author":"N Hamel","year":"2000","unstructured":"Hamel N, Black MJ, Ghadirian P, Foulkes WD (2000) No association between p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82: 757\u2013759","journal-title":"Br J Cancer"},{"key":"BF6600595_CR15","first-page":"5","volume":"7","author":"FR Hirsch","year":"2001","unstructured":"Hirsch FR, Franklin WA, Gazdar AF, Bunn Jr PA (2001) Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7: 5\u201322","journal-title":"Clin Cancer Res"},{"key":"BF6600595_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1126\/science.1905840","volume":"253","author":"M Hollstein","year":"1991","unstructured":"Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49\u201353","journal-title":"Science"},{"key":"BF6600595_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","volume":"52","author":"A Jemal","year":"2002","unstructured":"Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics, 2002. CA Cancer J Clin 52: 23\u201347","journal-title":"CA Cancer J Clin"},{"key":"BF6600595_CR18","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1093\/carcin\/16.9.2205","volume":"16","author":"X Jin","year":"1995","unstructured":"Jin X, Wu X, Roth JA, Amos CI, King TM, Branch C, Honn SE, Spitz MR (1995) Higher lung cancer risk for younger African-Americans with the Pro\/Pro p53 genotype. Carcinogenesis 16: 2205\u20132208","journal-title":"Carcinogenesis"},{"key":"BF6600595_CR19","first-page":"2753","volume":"60","author":"H Kawaguchi","year":"2000","unstructured":"Kawaguchi H, Ohno S, Araki K, Miyazaki M, Saeki H, Watanabe M, Tanaka S, Sugimachi K (2000) p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 60: 2753\u20132755","journal-title":"Cancer Res"},{"key":"BF6600595_CR20","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/carcin\/14.6.1085","volume":"14","author":"K Kawajiri","year":"1993","unstructured":"Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14: 1085\u20131089","journal-title":"Carcinogenesis"},{"key":"BF6600595_CR21","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/bjc.1995.69","volume":"71","author":"I Kinoshita","year":"1995","unstructured":"Kinoshita I, Dosaka-Akita H, Shindoh M, Fujino M, Akie K, Kato M, Fujinaga K, Kawakami Y (1995) Human papillomavirus type 18 DNA and E6-E7 mRNA are detected in squamous cell carcinoma and adenocarcinoma of the lung. Br J Cancer 71: 344\u2013349","journal-title":"Br J Cancer"},{"key":"BF6600595_CR22","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","volume":"88","author":"AJ Levine","year":"1997","unstructured":"Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323\u2013331","journal-title":"Cell"},{"key":"BF6600595_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/1097-0215(20000815)87:4<528::AID-IJC11>3.0.CO;2-O","volume":"87","author":"H Makni","year":"2000","unstructured":"Makni H, Franco EL, Kaiano J, Villa LL, Labrecque S, Dudley R, Storey A, Matlashewski G (2000) p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: effect of inter-laboratory variation. Int J Cancer 87: 528\u2013533","journal-title":"Int J Cancer"},{"key":"BF6600595_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/75586","volume":"25","author":"MC Marin","year":"2000","unstructured":"Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Crook T, Kaelin Jr WG (2000) A common polymorphism acts as an intragenic modifier of mutant p53 behaviour. Nat Genet 25: 47\u201354","journal-title":"Nat Genet"},{"key":"BF6600595_CR25","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1128\/MCB.7.2.961","volume":"7","author":"GJ Matlashewski","year":"1987","unstructured":"Matlashewski GJ, Tuck S, Pim D, Lamb P, Schneider J, Crawford LV (1987) Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 7: 961\u2013963","journal-title":"Mol Cell Biol"},{"key":"BF6600595_CR26","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1006\/mcbr.2000.0241","volume":"3","author":"EN Papadakis","year":"2000","unstructured":"Papadakis EN, Dokianakis DN, Spandidos DA (2000) p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun 3: 389\u2013392","journal-title":"Mol Cell Biol Res Commun"},{"key":"BF6600595_CR27","first-page":"1199","volume":"9","author":"LM Pierce","year":"2000","unstructured":"Pierce LM, Sivaraman L, Chang W, Lum A, Donlon T, Seifried A, Wilkens LR, Lau AF, Le Marchand L (2000) Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev 9: 1199\u20131204","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6600595_CR28","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/sj.onc.1201263","volume":"15","author":"D Sakamuro","year":"1997","unstructured":"Sakamuro D, Sabbatini P, White E, Prendergast GC (1997) The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15: 887\u2013898","journal-title":"Oncogene"},{"key":"BF6600595_CR29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner M, Huibregtse JM, Vierstra RD, Howley PM (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75: 495\u2013505","journal-title":"Cell"},{"key":"BF6600595_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/0092-8674(90)90409-8","volume":"63","author":"M Scheffner","year":"1990","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129\u20131136","journal-title":"Cell"},{"key":"BF6600595_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1099\/0022-1317-71-1-173","volume":"71","author":"PJ Snijders","year":"1990","unstructured":"Snijders PJ, van den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM (1990) The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol 71: 173\u2013181","journal-title":"J Gen Virol"},{"key":"BF6600595_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0304-3835(01)00867-9","volume":"179","author":"N Soulitzis","year":"2002","unstructured":"Soulitzis N, Sourvinos G, Dokianakis DN, Spandidos DA (2002) p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett 179: 175\u2013183","journal-title":"Cancer Lett"},{"key":"BF6600595_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S1368-8375(00)00139-1","volume":"37","author":"G Sourvinos","year":"2001","unstructured":"Sourvinos G, Rizos E, Spandidos DA (2001) p53 codon 72 polymorphism is linked to the development and not the progression of benign and malignant laryngeal tumours. Oral Oncol 37: 572\u2013578","journal-title":"Oral Oncol"},{"key":"BF6600595_CR34","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/30400","volume":"393","author":"A Storey","year":"1998","unstructured":"Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393: 229\u2013234","journal-title":"Nature"},{"key":"BF6600595_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/carcin\/22.3.515","volume":"22","author":"M Tada","year":"2001","unstructured":"Tada M, Furuuchi K, Kaneda M, Matsumoto J, Takahashi M, Hirai A, Mitsumoto Y, Iggo RD, Moriuchi T (2001) Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants. Carcinogenesis 22: 515\u2013517","journal-title":"Carcinogenesis"},{"key":"BF6600595_CR36","first-page":"1775","volume":"6","author":"T Takahashi","year":"1991","unstructured":"Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, Ueda R (1991) The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 6: 1775\u20131778","journal-title":"Oncogene"},{"key":"BF6600595_CR37","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1054\/bjoc.2000.1674","volume":"84","author":"AT Tandle","year":"2001","unstructured":"Tandle AT, Sanghvi V, Saranath D (2001) Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84: 739\u2013742","journal-title":"Br J Cancer"},{"key":"BF6600595_CR38","first-page":"435","volume":"9","author":"P Tenti","year":"2000","unstructured":"Tenti P, Vesentini N, Rondo Spaudo M, Zappatore R, Migliora P, Carnevali L, Ranzani GN (2000) p53 codon 72 polymorphism does not affect the risk of cervical cancer in patients from northern Italy. Cancer Epidemiol Biomarkers Prev 9: 435\u2013438","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BF6600595_CR39","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1128\/MCB.19.2.1092","volume":"19","author":"M Thomas","year":"1999","unstructured":"Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19: 1092\u20131100","journal-title":"Mol Cell Biol"},{"key":"BF6600595_CR40","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s002400100218","volume":"29","author":"GA Toruner","year":"2001","unstructured":"Toruner GA, Ucar A, Tez M, Cetinkaya M, Ozen H, Ozcelik T (2001) p53 codon 72 polymorphism in bladder cancer \u2013 no evidence of association with increased risk or invasiveness. Urol Res 29: 393\u2013395","journal-title":"Urol Res"},{"key":"BF6600595_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1165\/ajrcmb\/2.3.225","volume":"2","author":"J Viallet","year":"1990","unstructured":"Viallet J, Minna JD (1990) Dominant oncogenes and tumor suppressor genes in the pathogenesis of lung cancer. Am J Respir Cell Mol Biol 2: 225\u2013232","journal-title":"Am J Respir Cell Mol Biol"},{"key":"BF6600595_CR42","doi-asserted-by":"publisher","first-page":"15335","DOI":"10.1073\/pnas.93.26.15335","volume":"93","author":"KK Walker","year":"1996","unstructured":"Walker KK, Levine AJ (1996) Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 93: 15335\u201315340","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6600595_CR43","first-page":"129","volume":"5","author":"YC Wang","year":"1999","unstructured":"Wang YC, Chen CY, Chen SK, Chang YY, Lin P (1999) p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 5: 129\u2013134","journal-title":"Clin Cancer Res"},{"key":"BF6600595_CR44","first-page":"608","volume":"61","author":"I Zehbe","year":"2001","unstructured":"Zehbe I, Voglino G, Wilander E, Delius H, Marongiu A, Edler L, Klimek F, Andersson S, Tommasino M (2001) p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development. Cancer Res 61: 608\u2013611","journal-title":"Cancer Res"},{"key":"BF6600595_CR45","first-page":"F55","volume":"1288","author":"H zur Hausen","year":"1996","unstructured":"zur Hausen H (1996) Papillomavirus infections \u2013 a major cause of human cancers. Biochim Biophys Acta 1288: F55\u2013F78","journal-title":"Biochim Biophys Acta"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6600595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600595","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6600595.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:45:44Z","timestamp":1684413944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6600595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["BF6600595"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6600595","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}